Cardiovascular implantable electronic device infection: Difference between revisions

From IDWiki
No edit summary
No edit summary
Line 1: Line 1:
  +
== Background ==
  +
  +
* Ranges from local pocket infection to bacteremia to endocarditis
  +
  +
=== Epidemiology ===
  +
  +
* Occurs in about 2 per 1000 device-years
  +
  +
== Clinical Manifestations ==
  +
  +
* Isolated generator pocket infection: localized erythema, swelling, pain, tenderness, warmth, or drainage, with negative blood cultures
  +
* Isolated pocket erosion: device or lead exposed through the skin, with or without signs of infection
  +
* Lead infection: lead vegetation with positive blood cultures
   
 
==Investigations==
 
==Investigations==
   
*Blood cultures
+
*Blood cultures, ideally before antibiotics
*Transesophageal echocardiogram
+
*Transesophageal echocardiogram in most cases (in strong preference to transthoracic echocardiogram)
 
*Pacemaker pocket swab at time of removal
 
*Pacemaker pocket swab at time of removal
   
== Further Reading ==
+
== Management ==
  +
  +
* Management depends on blood culture findings
  +
** If positive, get TEE
  +
** If negative but high clinical suspicion, get TEE
  +
* If bacteremia or prior antibiotics
  +
** Valve vegetation ± bacteremia: remove CIED and treat as endocarditis
  +
** Lead vegetation ± bacteremia: remove CIED and treat for 2 weeks, or 4 weeks for [[Staphylococcus aureus]]
  +
** Negative TEE: consider CIED removal depending on microbiology and treat for 2 weeks
  +
* If no bacteremia but TEE positive, treat as above
  +
* If no bacteremia and no TEE or TEE negative
  +
** Pocket site infection or erosion: remove CIED and treat for 2 weeks
  +
** No pocket site infection: monitor
  +
* CIED can be reimplanted when blood cultures are negative for at least 72 hours
  +
  +
==Further Reading==
   
* 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. ''Heart Rhythm''. 2017;14(12):e503-e551. doi: [https://doi.org/10.1016/j.hrthm.2017.09.001 10.1016/j.hrthm.2017.09.001]
+
*2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. ''Heart Rhythm''. 2017;14(12):e503-e551. doi: [https://doi.org/10.1016/j.hrthm.2017.09.001 10.1016/j.hrthm.2017.09.001]
   
 
[[Category:Infectious diseases]]
 
[[Category:Infectious diseases]]

Revision as of 23:28, 29 July 2020

Background

  • Ranges from local pocket infection to bacteremia to endocarditis

Epidemiology

  • Occurs in about 2 per 1000 device-years

Clinical Manifestations

  • Isolated generator pocket infection: localized erythema, swelling, pain, tenderness, warmth, or drainage, with negative blood cultures
  • Isolated pocket erosion: device or lead exposed through the skin, with or without signs of infection
  • Lead infection: lead vegetation with positive blood cultures

Investigations

  • Blood cultures, ideally before antibiotics
  • Transesophageal echocardiogram in most cases (in strong preference to transthoracic echocardiogram)
  • Pacemaker pocket swab at time of removal

Management

  • Management depends on blood culture findings
    • If positive, get TEE
    • If negative but high clinical suspicion, get TEE
  • If bacteremia or prior antibiotics
    • Valve vegetation ± bacteremia: remove CIED and treat as endocarditis
    • Lead vegetation ± bacteremia: remove CIED and treat for 2 weeks, or 4 weeks for Staphylococcus aureus
    • Negative TEE: consider CIED removal depending on microbiology and treat for 2 weeks
  • If no bacteremia but TEE positive, treat as above
  • If no bacteremia and no TEE or TEE negative
    • Pocket site infection or erosion: remove CIED and treat for 2 weeks
    • No pocket site infection: monitor
  • CIED can be reimplanted when blood cultures are negative for at least 72 hours

Further Reading

  • 2017 HRS expert consensus statement on cardiovascular implantable electronic device lead management and extraction. Heart Rhythm. 2017;14(12):e503-e551. doi: 10.1016/j.hrthm.2017.09.001

References

  1. ^  Muhammad R. Sohail, Daniel Z. Uslan, Akbar H. Khan, Paul A. Friedman, David L. Hayes, Walter R. Wilson, James M. Steckelberg, Sarah Stoner, Larry M. Baddour. Management and Outcome of Permanent Pacemaker and Implantable Cardioverter-Defibrillator Infections. Journal of the American College of Cardiology. 2007;49(18):1851-1859. doi:10.1016/j.jacc.2007.01.072.